Supernus Pharmaceuticals | Lucro Operacional



Operating Profit Alterar Data
Abbott USD 1.91B 41M 2024-12
ANI Pharmaceuticals USD -4378000 16.14M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Eisai JPY 27.56B 13.14B 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Indivior 94M 226M 2024-09
Novo Nordisk 33.82B 7.89B 2024-09
Pacira USD 24.7M 164.23M 2024-12
Perrigo USD 112.7M 37.4M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Xeris Pharmaceuticals USD -12893000 4.71M 2024-09



Supernus Pharmaceuticals Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.